American International Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

American International Group’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,103	Closed	-$88.1K	–	3210
2023 Q1	$88.1K	Buy	14,103 +281	+2%	+$1.71K	﹤0.01%	2521
2022 Q4	$84.3K	Sell	13,822 -50	-0.4%	-$407	﹤0.01%	2585
2022 Q3	$166K	Buy	13,872 +195	+1%	+$2.55K	﹤0.01%	2265
2022 Q2	$172K	Buy	13,677 +899	+7%	+$8.37K	﹤0.01%	2288
2022 Q1	$144K	Sell	12,778 -900	-7%	-$9.91K	﹤0.01%	2433
2021 Q4	$242K	Sell	13,678 -409	-3%	-$8.63K	﹤0.01%	2260
2021 Q3	$324K	Buy	14,087 +6,489	+85%	+$141K	﹤0.01%	2129
2021 Q2	$177	Sell	7,598 -279	-4%	-$7.1K	﹤0.01%	2587
2021 Q1	$245	Buy	+7,877	New	+$274K	﹤0.01%	2264

Other funds holding KNTE

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American International Group's KNTE Position: Q2 2023 in Review

American International Group sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2023, closing a stake of 14,103 shares — an estimated $88.1K sold.

American International Group first reported a position in KNTE in Q1 2021 and held it in 9 quarters. The position peaked at $324K in Q3 2021. 72 funds tracked by Wall St. Rank hold KNTE as of Q2 2023.

American International Group reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
American International Group sold 14,103 Kinnate Biopharma Inc. Common Stock shares in Q2 2023, an estimated $88.1K.
American International Group first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2021 and held it in 9 quarters.
American International Group's Kinnate Biopharma Inc. Common Stock position peaked at $324K in Q3 2021.
72 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.